C-Max
How C-Max Works
C-Max utilizes the powerful combination of vitamin K3 and Alpha Lipoic Acid (ALA) to significantly boost the effects of high-dose vitamin C. This formula enhances the production of reactive oxygen species (ROS), creating oxidative stress that targets and disrupts cancer cells. Together, these ingredients work to amplify vitamin C's potential benefits in promoting cell health and supporting your body’s defense system.
How C-Max Works
C-Max employs two redox cycling agents, vitamin K3 and Alpha Lipoic Acid (ALA), to drastically enhance the anti-cancer qualities of its high dose of vitamin C. When combined with redox cycling agents, vitamin C can undergo redox reactions more efficiently, leading to increased production of reactive oxygen species (ROS) that can induce oxidative stress and ultimately promote cancer cell death.
Testimonials
How C-Max Works
Better Than Vitamin C Alone
C-Max employs two redox cycling agents, vitamin K3 and Alpha Lipoic Acid (ALA), to drastically enhance the anti-cancer qualities of its high dose of vitamin C. When combined with redox cycling agents, vitamin C can undergo redox reactions more efficiently, leading to increased production of reactive oxygen species (ROS) that can induce oxidative stress and ultimately promote cancer cell death.
Helps Immune Cells "See" Cancer
Vitamin C and K3 together allow the immune system to "see" cancer cells better, enhancing the innate immune system's ability to locate and kill them.
Better Tumor Penetration
C-Max liposomes are particles specifically designed to penetrate into tumors. During production, C-Max liposomes are tightly controlled so as to conform to the appropriate size for maximum tumor penetration.
SAFE for your body
Unlike many cancer medications, C-Max is completely safe for normal human physiology. In fact, C-Max vitamins have passed stage two FDA trials for safety.
Dosing: For optimal results and to acclimate your body to C-Max, we recommend a carefully structured dosing regimen. C-Max uses a dosing size of 25 mL. (25 mL is equal to 1 Tbsp + 2 teaspoons; or 5 teaspoons.) New users are advised to start with 25 mL on the first day. This helps gauge tolerance and allows the body to acclimate. If the initial 25 mL dose is well-tolerated, proceed to the full protocol of three 25-mL doses per day. Administer one 25 mL dose prior to breakfast, another 25 mL prior to lunch, and a final 25 mL dosage before dinner.
Upon achieving the full dosage, maintain a schedule of at least three administrations per week. An ideal regimen would be Monday, Wednesday, and Friday, considering the extended circulation of liposomes for up to 48 hours.
For individuals with a lower body mass, a modified dosage of 5 teaspoons (tsp) daily, 7 days per week, is suggested. Aim to maintain interval of 2 hours between each teaspoon dose (again, it’s best to consume each dose on an empty stomach or prior to meals). Under both protocols, the typical consumption rate is approximately one bottle per week.
The standard treatment duration spans 1 to 3 months. After the initial month, we recommend undergoing imaging or blood tests to evaluate tumor markers and the reduction in mass, which will help in assessing the treatment’s effectiveness for the particular case.
Quality Assurance
IVtoGo products adhere to the same stringent quality control standards as pharmaceutical drugs. To that end, each batch passes the same documentation and sanitation standards set by the FDA for cGMP compliance and the pharmaceutical industry in general. All products utilize only the purest ingredients on the supplement market.
Each batch undergoes two tests for all common heavy metals and pathogens. Laboratory assays occur both before and after bottling. IVtoGo utilizes ultrapure water (exceeding pharmaceutical grade). Also, plastic bottles, which pose great risk of plastic contamination to liposomes, are avoided. Bottles are pharmaceutical grade glass only.
